Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Truc T Tran

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Biorxiv : the Preprint Server for Biology|August 30, 2023
LiaX is a surrogate marker for cell-envelope stress and daptomycin non-susceptibility in <i>Enterococcus faecium</i>Dierdre B Axell-House, Shelby R Simar, Diana Panesso, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2024
LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in <i>Enterococcus faecium</i>Dierdre B Axell-House, Shelby R Simar, Diana Panesso, et al.
Open Forum Infectious Diseases|February 14, 2022
Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)German A Contreras, Jose M Munita, Shelby Simar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative ReviewSarah B Doernberg, Cesar A Arias, Deena R Altman, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
The Journal of Infectious Diseases|July 8, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Biorxiv : the Preprint Server for Biology|August 30, 2023
LiaX is a surrogate marker for cell-envelope stress and daptomycin non-susceptibility in <i>Enterococcus faecium</i>Dierdre B Axell-House, Shelby R Simar, Diana Panesso, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2024
LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in <i>Enterococcus faecium</i>Dierdre B Axell-House, Shelby R Simar, Diana Panesso, et al.
Open Forum Infectious Diseases|February 14, 2022
Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)German A Contreras, Jose M Munita, Shelby Simar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative ReviewSarah B Doernberg, Cesar A Arias, Deena R Altman, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
The Journal of Infectious Diseases|July 8, 2025
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS)Shelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 9